Still's disease is a rare disorder of unknown origin characterised by high spiking fever, evanescent rash, and arthritis, with an afternoon exacerbation'; the main biological feature is neutrophilic leucocytosis. 2 We expected that the evolution of the disease, the articular sequelae, or other characteristics would differ in these two groups. No differences were significant, however, except for the occurrence of three cases of amyloidosis in group 2 and none in group 1. Two of these cases of amyloidosis have been reported elsewhere."
All patients had multiple flare ups of Still's disease requiring large doses of corticosteroids and were dependent on these drugs during the first phase of the disease. The outcome at 10 years may be summarised as follows: 1. The appearance of sequelae was delayed for years in both groups. In group 1 only one patient showed any articular sequela before age 15. Figure 3a shows the evolution of articular damage between childhood and adulthood. In group 2 the joint destructions appeared also between one and eight years after the diagnosis.
2. The arthritis was difficult to control in both groups. In group 1 (10 patients with juvenile onset Still's disease) two patients still have persistent joint pain and inflammation. Both are being treated with corticosteroids; one of them is also taking methotrexate 7S5 mg/week Eight patients are in clinical remission: two without any treatment, three with low dose corticosteroids, and three with other drugs (methotrexate 7-5 mg/week or D-penicillamine 600 mg/day or piroxicam 20 mg/day). In group 2 (eight patients with adult onset Still's disease) two patients-one of whom died-developed renal insufficiency due to amyloidosis and one died from a digestive haemorrhage caused by amyloidosis. In another patient Still's disease remains active, requiring corticosteroids. Two have achieved a complete remission and take no treatment; three are pain free while taking prednisone 12 mg/day or methotrexate 7-5 mg weekly, or D-penicillamine 600 mg/day respectively.
Overall, the joint lesions were common and devastating in both groups; hip lesions were the most serious. Only seven patients were free from hip pain. Nine patients had severe hip destruction requiring 13 total hip prostheses. Hip cups (three) gave poor results. Figures 3a  and b show the patients' lesions. The wrist was injured in five patients (two had bilateral lesions), the tarsus in two, the knee in one, and the shoulder in one. It was of note that the finger joints were spared. Three patients have ankylosis of the cervical spine, including one with scoliosis of the entire spine due to the disease. One patient in group 2 underwent an arthrodesis of the foot. Multiple articular injections (corticosteroids, osmic acid) were given.
3. Iatrogenic complications occurred due to the high doses of anti-inflammatory drugs prescribed: cushingoid appearance (two); aseptic necrosis of the femoral head (one), of the lower extremity of the femur (one), and of the ankle (two); one patient bled from a gastroduodenal ulcer; and two patients in group 1 had severe growth sequelae. 4 According to our data, the articular sequelae take five to seven years to appear. As the disease commonly begins in late childhood the follow up time is generally insufficient to observe them as children.
We found that the overall long term prognosis of Still's disease is clearly good for the systemic manifestations, but not for the articular ones: severe joint lesions do occur and often leave the patients with severe sequelae. The incidence of hip injury is striking: 13 total hip prostheses had to be placed before age 45 in seven patients. This agrees with other series of juvenile arthritis7 and ofadult Still's disease.2 89 No treatment was effective in preventing those long term complications. Clearly, the disease has a strong (but not obligatory) predilection for the joints and, in particular, the hips. Once the destructive process has begun the injury worsens rapidly, requiring a prosthesis on average five years after the first x ray signs. As our patients were treated with the maximum tolerable doses of corticosteroids, aspirin, and non-steroidal anti-inflammatory drugs, however, the iatrogenic effects were common. None of the anti-inflammatory drugs used was effective in preventing long term damage of the joints. We are now experimenting with innovative drug regimens, such as low dose methotrexate,12 which may provide better control of Still's disease in the long term. We are also considering early synoviortheses for the affected joints in order to prevent long term destruction.
